|
|
 |
|
|
|
|
We are Dedicated
to Continuous Innovation for your Well-Being
|
|
 |
|
Allergan, Inc., with
headquarters in Irvine, California, is a global specialty pharmaceutical
company that develops and commercializes innovative products
for the eye care, neuromodulator, skin care and other specialty
markets. In addition to its discovery-to-development research
programs, Allergan has global marketing and sales capabilities
in over 100 countries that deliver value to our customers, satisfy
unmet medical needs and improve people's lives.
Driven by technology
and innovation, Allergan addresses the needs of consumers across
the world with over 5,000 employees worldwide, 4 world-class
Research and Development facilities and 3 state-of-the-art manufacturing
plants.
|
|
|
|
|
|
|
::
OPHTHALMIC PHARMACEUTICALS
Years of experience as a global leader in eye
care have resulted in the rapid growth of Allergan's ophthalmic
pharmaceuticals business. With an expertise in discovering
and developing new therapeutic agents for conditions and diseases
of the eye, Allergan is positioning itself to take over the
No. 1 position in the global ophthalmic market by establishing
the largest ophthalmic sales force in the world and by making
significant investments in eye care research and development
projects. As of the beginning of 2002, Allergan has the
largest sales force in ophthalmology in North American, Europe,
Latin America and Asia, outside of Japan. The Allergan
sales force has been ranked No. 1 in the U.S. for the fourth
year in a row by ophthalmologists according to an independent
survey by Scott-Levin and was again ranked first in Canada in
an independent survey conducted by Market Research Canada.
|
|
|
::
BOTOX® / NEUROMODULATOR
Over the past decade,
the uses of BOTOX® (botulinum toxin type A) have expanded as
scientists and physicians continue to recognize its broad applicability.
Originally used in the treatment of certain ophthalmic
movement disorders, BOTOX® therapy is now widely accepted in
many regions around the world as the gold standard for indications
ranging from therapeutic neuromuscular disorders and related
pain to cosmetic facial aesthetics. BOTOX® therapy also
carries the unique distinction of being the only product of
its kind with over 10 years of successful clinical experience
in people worldwide.
|
|
|
::
SKIN CARE
Allergan focused its resources on the high growth
markets of acne and psoriasis in the U.S. and Canada while modestly
building its presence outside North America. Combined,
the U.S. topical acne and psoriasis markets generated over $900
million in 2001 and grew by over 16% from 2000, making them
two of the most attractive segments in the overall dermatology
market. Within these markets, Allergan performed excellently,
recording the highest in-market growth of any dermatology company.
|
|
|
|
